257 related articles for article (PubMed ID: 6268963)
1. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
2. Interaction of vasoactive intestinal peptide with human blood mononuclear cells.
Guerrero JM; Prieto JC; Elorza FL; Ramirez R; Goberna R
Mol Cell Endocrinol; 1981 Feb; 21(2):151-60. PubMed ID: 6260561
[TBL] [Abstract][Full Text] [Related]
3. The interaction of vasoactive intestinal peptide (VIP) with isolated bovine thyroid plasma membranes.
Molinero P; Calvo JR; Goberna R; Guerrero JM
Biochem Biophys Res Commun; 1985 May; 128(3):1336-41. PubMed ID: 2988535
[TBL] [Abstract][Full Text] [Related]
4. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
5. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1.
Emami S; Gespach C; Forgue-Lafitte ME; Broer Y; Rosselin G
Life Sci; 1983 Aug; 33(5):415-23. PubMed ID: 6192308
[TBL] [Abstract][Full Text] [Related]
6. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
7. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate.
Laburthe M; Prieto JC; Amiranoff B; Dupont C; Hui Bon Hoa D; Rosselin G
Eur J Biochem; 1979 May; 96(2):239-48. PubMed ID: 88368
[TBL] [Abstract][Full Text] [Related]
8. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts.
Beed EA; O'Dorisio MS; O'Dorisio TM; Gaginella TS
Regul Pept; 1983 Apr; 6(1):1-12. PubMed ID: 6306732
[TBL] [Abstract][Full Text] [Related]
10. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
[TBL] [Abstract][Full Text] [Related]
11. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
Broyart JP; Dupont C; Laburthe M; Rosselin G
J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
[TBL] [Abstract][Full Text] [Related]
12. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
14. Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat.
Prieto JC; Laburthe M; Hoa DH; Rosselin G
Acta Endocrinol (Copenh); 1981 Jan; 96(1):100-6. PubMed ID: 6257013
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase.
Besson J; Malassiné A; Ferré F
Regul Pept; 1987 Nov; 19(3-4):197-207. PubMed ID: 2829291
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.
Taton G; Delhaye M; Camus JC; de Neef P; Chatelain P; Robberecht P; Christophe J
Pflugers Arch; 1981 Sep; 391(3):178-82. PubMed ID: 6126856
[TBL] [Abstract][Full Text] [Related]
17. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
20. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
